16:03 EDT Fate Therapeutics files to sell 3.64M shares of common stock for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FATE:
- Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
- Fate Therapeutics price target raised to $6 from $2 at BofA
- Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
- Fate Therapeutics prices 14.5M shares at $5.50 in underwritten offering
- Fate Therapeutics to Present at Upcoming March Investor Conferences